000513 Livzon Pharmaceutical Group Inc.
- 37.74
- +0.62+1.67%
About Livzon Pharmaceutical Group Inc. Company
The company was founded in January 1985. It is a comprehensive pharmaceutical group company integrating R&D, production and sales of pharmaceutical products, and is an A+H listed company. The company regards R&D innovation as the cornerstone of sustainable development, and continues to pay attention to new molecules and cutting-edge technologies in the global field of new drug research and development. Based on clinical value, differentiated forward-looking layout of innovative drugs and complex formulations with high barriers, the company focuses on the digestive tract, assisted reproduction, psychiatry, tumor immunity, etc., and has formed a complete product cluster and a differentiated product pipeline covering the entire R&D cycle. The company's main business is R&D, production and sales of pharmaceutical products. The main products include iLianan, Rivolol series products, Rebelix, Vitrex, Beiyi, Lisenbao, Lebald, Lifecon, Ripple, Conertin, Shenqi Fuzheng injection, antiviral granules, etc.; mirvastatin, acarbose, colistin sulfate, phenylalanine, vancomycin hydrochloride, daptomycin, mirbetaxim and ceftriaxone sodium, etc.; Mycoplasma pneumoniae IgM antibody detection reagents, antibody test reagents for human immunodeficiency Diagnostic reagent products such as kits and antinuclear antibody test kits. Corporate honors: Pearl Delle won the first Grand Prize for Outstanding Contribution to Science and Technology Progress in Zhuhai; Pearl Dole won the Grand Prize for Outstanding Contribution to Promoting Scientific and Technological Progress in Zhuhai; Jinqi Fuzheng Injection won the first prize of the 2006 China Society of Integrative Traditional Chinese and Western Medicine Science and Technology Award, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- baoguo zhu
- Chairman, Non-executive Directors, Chairman of the Environmental, Social and Governance Committee, Chairman of the Strategy Committee
- 3.25M
- guoxiang xu
- Vice Chairman, Executive Director, VP
- 5.47M
- desheng tao
- Vice Chairman, Non-executive Directors, Strategy Committee Member, Nomination Committee Members
- 3.00M
- yanggang tang
- Executive Director, President, Strategy Committee Member, Member of the Environmental, Social and Governance Committee
- 5.81M
- qingfeng qiu
- Non-executive Directors
- 96.00K
- lijie cui
- Independent Non-Executive Director, Member of the Remuneration and Assessment Committee
- 120.00K
- qiusheng tian
- Independent Non-Executive Director, Member of the Environmental, Social and Governance Committee, Nomination Committee Members, Chairman of the Remuneration and Assessment Committee, Audit Committee Member
- 120.00K
- hua bai
- Independent Non-Executive Director, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee, Member of the Environmental, Social and Governance Committee
- 120.00K
- huiyuan luo
- Independent Non-Executive Director, Audit Committee Member, Chairman of the Nomination Committee
- 120.00K
- jinhua huang
- Independent Non-Executive Director, Member of the Environmental, Social and Governance Committee
- 120.00K
- liang yang
- Board Secretary, VP
- 2.36M
- delong ye
- Securities Affairs Representative
- --
- maolin wang
- Chief Supervisor, Employee Supervisors
- 1.31M
- yin tang
- Auditors
- 48.00K
- huamin huang
- Auditors
- 48.00K
- daping liu
- VP
- --
- yanxia si
- VP, Chief Financial Officer
- 3.54M
- jun du
- VP
- 5.17M
- daihong yang
- VP
- 3.72M
- yuxuan huang
- VP
- 2.39M
Analysis
Price Target
No Data
No Data